NR3C2 and metabolic syndrome: Aldosterone excess and subsequent activation of the mineralocorticoid receptor (MR) are involved not only in hypertension but also in obesity and its cardiometabolic complications, such as dyslipidemia, type 2 diabetes mellitus (T2DM), and chronic kidney disease (CKD) [5, 6].